MétaCan
Menu
Back to cohort
Record W1590504688 · doi:10.1158/1538-7445.am2014-3804

Abstract 3804: CPA-7, an inhibitor of STAT3, is a potent tumoricidal agent in peripheral tumor models and is impermeable to the CNS

2014· article· en· W1590504688 on OpenAlexaff
Hikmat Assi, Chris Paran, Jon Savakus, James Hoeschle, Leda Raptis, Pedro R. Löwenstein, María G. Castro

Bibliographic record

VenueCancer Research · 2014
Typearticle
Languageen
FieldPharmacology, Toxicology and Pharmaceutics
TopicBioactive Compounds and Antitumor Agents
Canadian institutionsQueen's University
Fundersnot available
KeywordsSurvivinGliomaCancer researchSTAT3CisplatinApoptosisMedicineBiologyChemistryMolecular biologyChemotherapyInternal medicineBiochemistry

Abstract

fetched live from OpenAlex

Abstract Analogues of the prototypical cancer drug cisplatin number by the hundreds with variable effects on DNA and signal transduction. Of these compounds, CPA-7 has been shown to elicit potent tumoricidal activity by preferentially targeting STAT3 in transformed cells. In this study, we characterized the response of rodent and human glioma cells to STAT3 inhibition by CPA-7. In addition, we determined if CPA-7 administration is sufficient for the induction of tumor regression in intracranial and peripheral mouse tumor models. Cultured glioma cells treated with CPA-7 ceased to proliferate and underwent apoptosis. Induction of apoptosis was associated with reduction of phosphorylated STAT3 and downstream transcriptional products such as cyclin D, survivin, and Bcl-xl. Although CPA-7 inhibits STAT3 preferentially, we observed an inhibition of STAT1 at doses higher than 30uM. Furthermore, mice bearing GL26 flank tumors underwent complete tumor regression in response to CPA-7 administration. This potent therapeutic effect of CPA-7 could not be duplicated in mice bearing intracranial GL26 brain tumors as that group became moribund at the same time as vehicle treated mice. Western blot and immunohistochemistry analysis of tumors isolated from CPA-7 treated mice demonstrated a reduction of phosphorylated STAT3 in peripheral but not intracranial tumors. This data suggests that CPA-7 is impermeable to the brain as a consequence of its molecular structure. Permeability measurements of CPA-7 using the PAMPA assay support this notion. These observations were corroborated in the B16-f0 and B16-f10 mouse melanoma models. Inhibition of STAT3 has been shown to be an effective strategy at inducing tumor regression in multiple cancer types. Although the discovery of effective and specific inhibitors has been limited, we believe that CPA-7 is a compound with potential therapeutic activity for peripheral solid tumors and warrants further evaluation and pharmacological characterization. Supported by NIH/NINDS Citation Format: Hikmat Assi, Chris Paran, Jon Savakus, James Hoeschle, Leda Raptis, Pedro R. Lowenstein, Maria G. Castro. CPA-7, an inhibitor of STAT3, is a potent tumoricidal agent in peripheral tumor models and is impermeable to the CNS. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 3804. doi:10.1158/1538-7445.AM2014-3804

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesInsufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.270
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0020.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.274
GPT teacher head0.509
Teacher spread0.235 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2014
Admission routes1
Has abstractyes

Explore more

Same venueCancer ResearchSame topicBioactive Compounds and Antitumor AgentsFrench-language works237,207